Funder
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Subject
Public Health, Environmental and Occupational Health,Epidemiology
Reference46 articles.
1. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis;Amoako;Int. J. Drug Policy,2021
2. Clinicians’ views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs;Asher;Subst. Use Misuse,2016
3. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program;Butner;J Subst Abuse Treat,2017
4. Centers for Disease Control and Prevention, 2017. Increase in hepatitis C infections linked to worsening opioid crisis. https://www.cdc.gov/nchhstp/newsroom/2017/hepatitis-c-and-opioid-injection.html.
5. Centers for Disease Control and Prevention, 2021. New estimates reveal declines in hepatitis C treatment in the U.S. between 2005 and 2020. https://www.cdc.gov/nchhstp/newsroom/2021/2014-2020-hepatitis-c-treatment-estimates.html.